FII Holdings

SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE1808.4014.1 (+0.79 %)
PREV CLOSE ( ) 1794.30
OPEN PRICE ( ) 1808.00
BID PRICE (QTY) 1808.25 (8)
OFFER PRICE (QTY) 1809.25 (36)
VOLUME 28102
TODAY'S LOW / HIGH ( )1792.40 1814.60
52 WK LOW / HIGH ( )1547.25 1917.15
NSE1809.3015.1 (+0.84 %)
PREV CLOSE( ) 1794.20
OPEN PRICE ( ) 1807.00
BID PRICE (QTY) 1809.20 (8)
OFFER PRICE (QTY) 1809.30 (25)
VOLUME 688816
TODAY'S LOW / HIGH( ) 1792.50 1814.50
52 WK LOW / HIGH ( )1548 1916.6
upfii downfii 
Current Quarter
Prev Quarter
Company Quarter Ended 202603 % of Share Quarter Ended 202512 % of Share Changeupfii

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.